Optometrists in Copperas Cove, TX Accepting Medicare
5 Optometrists found. Showing 1 - 5
 Cove Optical Optometrist Medicare: Not Enrolled in Medicare Practice Location: 304 E Highway 190, Copperas Cove, TX 76522 Phone: 254-547-2020 Fax: 254-542-6060 |
 Mrs. Micheline D Young, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 304 E Highway 190, Copperas Cove, TX 76522 Phone: 254-547-2020 Fax: 254-542-6060 |
Cove Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 304 E Highway 190, Copperas Cove, TX 76522 Phone: 254-547-2020 Fax: 254-542-6060 |
Chinelo Okpalaeze, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 98 Cove Terrace Shopping Ctr, Copperas Cove, TX 76522 Phone: 254-542-2020 |
 Dr. John Thomas Berg, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2724 E Highway 190, Copperas Cove, TX 76522 Phone: 254-542-7540 Fax: 254-542-7541 |
News Archive
Neurons generated at different life stages can impact olfactory behavior in mice, research shows
New research from North Carolina State University shows that neurons generated at different life stages in mice can impact aspects of their olfactory sense and behavior.
ASN joins ABIM Foundation's Choosing Wisely campaign
The American Society of Nephrology (ASN), the world's leading kidney organization, joins the American Board of Internal Medicine (ABIM) Foundation, eight other leading national medical specialty societies and Consumer Reports in the Choosing Wisely campaign. This campaign will help physicians, patients and other health care professionals address overuse of health care resources in the United States.
Aegerion prices initial public offering of common stock
Aegerion Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at $9.50 per share, before underwriting discounts and commissions.
'Romneycare' continues to draw political focus
As one former GOP governor softens his criticism, Massachusetts' current Democratic governor chimes in with kudos for the state health overhaul that Romney oversaw when he was that state's chief executive.
Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer
Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved COMETRIQ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid cancer (MTC).
› Verified 8 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Occupational Therapists
Podiatrists